drugs

Merck Sees High-Single-Digit EPS Growth Through '13 - Wall Street Journal
MiamiHerald.comMerck Sees High-Single-Digit EPS Growth Through '13Wall Street JournalMerck makes the blockbuster allergy and asthma drug Singulair, and expects the Schering deal to improve its late-stage pipeline of experimental drugs. ...Merck, now No. 2 drugmaker, set for future buysThe Associated PressMerck research chief sees more deals aheadOnet.plMerck and Schering-Plough MergeDOTmed.com (press release)EasyBourse.com�-MarketNewsVideo.com�-Philadelphia Inquirerall 487 news articles��

Blog Content